|
Cato T. Laurencin, M.D., Ph.D., a Lillian Pratt Distinguished Professor and Chairman of the Department of Orthopaedic Surgery at the University of Virginia was elected as the National Medical Association's Speaker of the House of Delegates (HOD) at their Annual Convention and Scientific Assembly in Philadelphia.
The Speaker of the House of Delegates serves a two-year term and acts as the parliamentarian. The House of Delegates is the legislative body of the National Medical Association. Representatives to the House of Delegates consist of association and societies from the 50 states, District of Columbia, and the Virgin Islands. Prior to becoming Speaker of the House of Delegates, Dr. Laurencin was vice chairman of the HOD and before that he was a Resident Trustee. He has a long history of active involvement with the National Medical Association.
A native Philadelphian, Dr. Laurencin earned his B.S.E. in Chemical Engineering from Princeton University, and pursued a topical program in polymer science and engineering. He went on the Harvard Medical School where he earned his M.D., graduating Magna Cum Laude, while simultaneously completing a Ph.D. degree in Biochemical Engineering/Biotechnology at M.I.T., where he was named a Hugh Hampton Young Scholar.
Dr. Laurencin is a fellow of the College of Surgeons and a fellow of the American Academy of Orthpaedic Surgeons and a fellow of the American Institute of Medical and Biological Engineering among other prestigious affiliations. Dr. Laurencin has lectured on shoulder surgery as an American Orthopaedic Association-American, British, Canadian (ABC) traveling fellow . He also completed a fellowship in Sports Medicine and shoulder surgery in New York, where he worked with team physicians for the New York Mets and St. John's University.
Dr. Laurencin's commitment to public service is exemplified by his active involvement as a member of the National Advisory Council for Musculoskeletal and Skin Disease, National Institutes of Health, and the National Science Board of the Food and Drug Administration among others.
October 28, 2004 |
